Calprotectin Levels in HIV‐Infected Patients: Correlations With Disease Progression and Intestinal Inflammation
AIDS Research and Treatment · 2026-01 · 2026 (1)
DOI: 10.1155/arat/5543700 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Treatment, online erschienen am 26.06.2026. Verfasst von Huiyun Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, People's Hospital of Leshan, Leshan, China, leshan-hospital.com. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Persistent intestinal inflammation remains a significant concern in HIV‐infected patients despite effective antiretroviral therapy (ART). Calprotectin (S100A8/A9), a calcium‐binding protein complex involved in inflammatory signaling, has emerged as a potential biomarker in various inflammatory disorders; however, its role in HIV‐related intestinal inflammation has not been extensively studied.
Methods
This study recruited 15 AIDS‐stage patients, 15 asymptomatic HIV‐infected patients, and 10 healthy controls from Chengdu Anal and Intestinal Specialized Hospital between April and August 2023. Serum, fecal samples, and colonic mucosal biopsies were collected. Calprotectin expression was quantified using enzyme‐linked immunosorbent assay (ELISA), immunohistochemistry, and Western blot analysis. Histopathological evaluation was performed using hematoxylin and eosin staining. Statistical correlations between calprotectin levels and clinical indicators, including CD4+ T‐cell counts, were analyzed.
Results
Serum and fecal calprotectin concentrations were significantly elevated in HIV‐infected groups compared with controls, with the highest levels observed in AIDS‐stage patients ( p < 0.05). Colonic mucosal inflammation severity correlated positively with S100A8/A9 protein expression ( p < 0.05). Calprotectin expression inversely correlated with CD4+ T‐cell counts (serum: r = −0.509; feces: r = −0.520, both p < 0.001). Strong correlations were observed between calprotectin expression in serum, feces, and intestinal mucosal tissues.
Conclusions
Calprotectin serves as a sensitive biomarker reflecting intestinal inflammation severity and immune dysfunction in HIV‐infected individuals. Serum and fecal calprotectin assays offer noninvasive, reliable methods for evaluating disease progression and inflammatory status and potentially guiding clinical management in HIV.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, People's Hospital of Leshan, Leshan, China, leshan-hospital.com.
- Department of Dermatology, Sichuan Provincial People's Hospital Medical Group Chuantou Xichang Hospital, Xichang, China.
- Department of Proctology and Dermatology, Chengdu Anorectal Hospital, Chengdu, China.
- Institute of Dermatology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, uestc.edu.cn.
ORCID-Profile: Huiyun Fan, Zhongyun Deng, Fan Cui
Zitieren
APA
Fan, H., Deng, Z., Qing, Y., Rang, Z., & Cui, F. (2026). Calprotectin Levels in HIV‐Infected Patients: Correlations With Disease Progression and Intestinal Inflammation. AIDS Research and Treatment, 2026(1). https://doi.org/10.1155/arat/5543700
Vancouver
Fan H, Deng Z, Qing Y, Rang Z, Cui F. Calprotectin Levels in HIV‐Infected Patients: Correlations With Disease Progression and Intestinal Inflammation. AIDS Research and Treatment. 2026;2026(1). doi:10.1155/arat/5543700
BibTeX
@article{Fan2026,
author = {Fan, Huiyun and Deng, Zhongyun and Qing, Yong and Rang, Zhen and Cui, Fan},
title = {Calprotectin Levels in HIV‐Infected Patients: Correlations With Disease Progression and Intestinal Inflammation},
journal = {AIDS Research and Treatment},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/arat/5543700}
}
EUVIMED